Previous Article | Next Article ![]()
Journal of Clinical Microbiology, October 2006, p. 3760-3767, Vol. 44, No. 10
0095-1137/06/$08.00+0 doi:10.1128/JCM.01435-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Birgitta Schweickert,1
Petra Buchholz,1
Ulf B. Göbel,1
Timo Ulrichs,2,
Peter Seiler,2,
Dirk Theegarten,3,¶ and
Annette Moter1*
Institut für Mikrobiologie und Hygiene, CharitéUniversitätsmedizin Berlin, Dorotheenstrasse 96, 10117 Berlin, Germany,1 Abteilung für Immunologie, Max-Planck-Institut für Infektionsbiologie, Schumannstrasse 21/22, 10117 Berlin, Germany,2 Abteilung für Pathologie, Ruhr-Universität Bochum, Universitätsstrasse 150, 44780 Bochum, Germany3
Received 11 July 2006/ Accepted 5 August 2006
|
|
|---|
|
|
|---|
Detection of mycobacteria in clinical specimens by conventional methods is difficult because of the low numbers of bacilli available, their slow growth, and their fastidious metabolism. Cultivation of M. leprae is still impossible. Recently, conventional methods such as acid-fast staining, culture, and phenotypic differentiation have been complemented by nucleic acid probes and amplification-based methods, substantially reducing the time to diagnosis (11).
Specific visualization of mycobacteria, e.g., by fluorescence in situ hybridization (FISH), would be a great help in directly identifying bacteria in clinical and environmental samples (11, 12). However, conventional oligonucleotide probes barely penetrate bacteria with cell walls containing mycolic acids. The relative hydrophobic character of PNA (peptide nucleic acid) probes compared to DNA analogues allows better diffusion through the hydrophobic cell wall of mycobacteria (19, 20). However, the FISH assays available so far are restricted to differentiation of tuberculous from nontuberculous Mycobacterium species in acid-fast bacillus-positive sputum smears or in culture (2, 6, 15, 21), as well as M. avium in potable-water biofilms (9).
There are several reports describing the detection of M. tuberculosis and M. avium subsp. paratuberculosis in tissue sections by staining with antibodies or in situ hybridization (ISH). Seiler and colleagues (18) used a polyclonal anti-M. bovis Bacille Calmette-Guerin serum for detection of cell wall-deficient M. tuberculosis in mouse tissue. Naser and colleagues (13) demonstrated M. avium subsp. paratuberculosis in tissue specimens from patients with Crohn's disease with a polyclonal antibody. Several authors have described the detection of mycobacterial DNA or RNA in tissue specimens of human or animal origin with ISH or in situ PCR techniques (3, 4, 5, 7, 8, 17). One paper reported on ISH with PNA probes, followed by signal amplification, to differentiate between M. tuberculosis complex and nontuberculous Mycobacterium spp. in archival biopsy and autopsy samples (24). All of the methods described so far either lack specificity (antibody-based staining), are laborious and time consuming, or do not distinguish single mycobacteria. Bacteria are not resolved properly but appear as a stained mass of uncertain identity.
Here we present an improved method using fluorescently labeled PNA probes for fast visualization and identification of members of the M. tuberculosis complex, M. avium, M. kansasii, and M. leprae in smears and tissue biopsies. A rapid (3-h) FISH procedure was established and evaluated by using mycobacteria cultured from clinical specimens. M. tuberculosis complex-, M. leprae-, and M. avium-specific PNA probes were used successfully for specific visualization of the respective mycobacteria in tissue sections from infected humans or animals. This technical improvement may have a great impact on the detection of mycobacteria in research or diagnostic laboratories, particularly in those which are unable or unwilling to invest into a highly sophisticated molecular genetic facility.
|
|
|---|
|
View this table: [in a new window] |
TABLE 2. Evaluation of PNA probe specificity
|
Mycobacteria in cells and in tissue sections. Adherent human antigen-presenting cells (APC) grown on microscope slides were infected with M. bovis BCG and fixed in 4% (vol/vol) paraformaldehyde for PNA-FISH. Sections (4 to 5 µm) of paraffin-embedded tissue from skin biopsy samples from a patient with leprosy, from lungs of M. tuberculosis-infected C57BL/6 mice (18), or from animals with Johne's disease were deparaffinized by immersion in xylol 100% (vol/vol, 10 min) and ethanol 100% (vol/vol, 5 min) three times. Lung tissue from one patient with culture-proven tuberculosis was embedded in cold polymerizing resin (Technovit 8100; Kulzer, Germany) as described by Moter and Göbel (11) and sectioned (3- to 4-µm thickness).
PNA probes. Probes MTBCCy3, MLEPTAMRA, MAVTAMRA, and MKATAMRA were designed for specific detection of members of the M. tuberculosis complex, M. leprae, M. avium, and M. kansasii 16S rRNA, respectively, with the 16S rRNA sequence database and the probe design program of the ARB software (http://www.arb-home.de/). Probes were chosen with regard to purine content and secondary structure, avoiding hairpin formations and inverse repeats. To assess their specificity, all probe sequences were compared to all of the 16S rRNA entries in the EMBL and GenBank databases currently (June 2006) accessible by using the programs BLASTN and FASTA of the HUSAR (version 4.0; Heidelberg UNIX Sequence Analysis Resources) program package (DKFZ, Heidelberg, Germany). The PNA probe BacUni-1Fluo (fluorescein), complementary to a region of the 16S rRNA gene conserved in the domain Bacteria (eubacterial probe), was used as a positive control (BacUni-1Fluo [5'-CTG CCT CCC GTA GGA-3']) (14, 16). MTBCCy3, MLEPTAMRA, and BacUni-1Fluo were purchased from Applied Biosystems (Foster City, Calif.), and MAVTAMRA and MKATAMRA were synthesized by TIB MOLBIOL (Berlin, Germany).
ISH. Culture-grown and fixed bacteria (2 to 5 µl) were spotted onto six-field microscope slides (Paul Marienfeld KG, Bad Mergentheim, Germany), air dried, dehydrated in 100% (vol/vol) methanol for 1 min and 100% (vol/vol) ethanol for 5 min, air dried again, and preheated to hybridization temperature. Slides with APC and tissue sections were preheated to hybridization temperature. Aliquots (10 µl for cultured bacteria and 20 to 60 µl for APC and tissue sections) of a hybridization mixture containing 10% (wt/vol) dextran sulfate (Merck, Darmstadt, Germany), 10 mM NaCl (Merck), 30 to 50% (vol/vol) formamide (Roth, Karlsruhe, Germany) (Table 1), 0.1% (wt/vol) sodium pyrophosphate (Merck), 0.2% (wt/vol) polyvinylpyrrolidone (Sigma Chemical Co., St. Louis, Mo.), 0.2% (wt/vol) Ficoll (Fluka Chemie AG, Basel, Switzerland), 5 mM disodium EDTA (Roth, Karlsruhe, Germany), 0.1% (vol/vol) Triton X-100 (Serva, Heidelberg, Germany), 50 mM Tris-HCl (pH 7.5), and a fluorescent probe(s) with a final concentration of 1 to 1.5 µmol/liter (Table 1) were applied to each sample. Slides were incubated at a temperature optimized for each PNA probe (Table 1) in a preheated moisture chamber in the dark for 30 min. After brief immersion in double-distilled water, slides were washed in preheated washing buffer (5 mM Tris, 15 mM NaCl, 0.1% [vol/vol] Triton X-100 [pH 10; Serva]) at hybridization temperature for 10 min. Following a brief immersion in double-distilled water, slides were air dried and mounted with 1 drop of Vectashield (Vector Laboratories, Inc., Burlingame, Calif.). Slides were incubated at hybridization temperature accordingly for 10 min.
|
View this table: [in a new window] |
TABLE 1. PNA probe sequences and hybridization conditionsa
|
|
|
|---|
For specificity control, we chose cultured Mycobacterium species with 16S rRNA sequences containing single base mismatches in the target region. Table 1 compiles probe sequences, complementary 16S rRNA sequences of target species and controls, and optimized hybridization conditions for sequence-specific FISH. M. marinum shows a single base mismatch at position 2 (from the 5' probe end) with probe MTBCCy3. To prevent unspecific hybridization of MTBCCy3 to M. marinum, high-stringency hybridization conditions (60°C, 50% formamide) were required. For M. chubuense and M. celatum, exhibiting single mismatches at positions 5 and 8 of the MTBCCy3 probe sequence, less-stringent hybridization conditions (55°C, 40% formamide) were sufficient to prevent unspecific binding (data not shown). For probes MAVTAMRA and MKATAMRA, exhibiting single base mismatches to M. haemophilum and M. intermedium or M. gordonae, respectively, unspecific binding was avoided by hybridization at 55°C and use of a formamide concentration of 30% or 40%, respectively. Since M. leprae has not yet been cultured, we used M. haemophilum (one mismatch at position 9) for evaluation of probe MLEPTAMRA. Low-stringency hybridization conditions (50°C, no formamide) resulted in strong fluorescence signals in M. haemophilum and showed the applicability of the probe for FISH. Increasing the temperature to 55°C and the formamide concentration to 30% resulted in a weak fluorescence signal with M. haemophilum, indicating M. leprae-specific FISH. Hybridization with a PNA probe for specific visualization of M. intracellulare was not successful. The probe sequence chosen had single mismatches to many different mycobacterial species at positions 1 and 2 from the 5' probe end. We were not able to establish hybridization conditions avoiding unspecific binding (data not shown).
The specificity of all probes and hybridization conditions was evaluated with a panel of 25 different mycobacterial species (Table 2) and 10 different gram-positive organisms (see Materials and Methods). Species with single mismatches to the probe were included in every FISH experiment to control for unspecific binding. In FISH experiments lacking a PNA probe, fixed bacterial cells showed no or little autofluorescence (data not shown). Eubacterial probe BacUni-1Fluo was used to check for rRNA content, permeability of fixed bacteria, and a successful FISH procedure in positive and negative controls in every experiment. All fixed bacteria were stained by the eubacterial probe and visible as single cells or clusters. However, microscopy with the Cy3-TAMRA filter set (specific probes) revealed bright fluorescence of the target organisms only. No or weak signals were observed for mycobacterial species with single mismatches in the probe binding region. All other species showed no fluorescence with the specific probes.
Identification of mycobacteria cultured from clinical specimens. PNA-FISH results for mycobacteria cultured from patient materials are listed in Table 3. Mycobacterial isolates (n = 52) were fixed and hybridized with probes MTBCCy3 and BacUni-1Fluo. If the MTBCCy3 FISH was negative, M. avium- and M. kansasii-specific probes combined with BacUni-1Fluo were used. All FISH experiments were done in a blinded fashion, and results were compared to conventional identification after completion. FISH with probes MTBCCy3, MAVTAMRA, and MKATAMRA resulted in the correct identification of all M. tuberculosis, M. avium, and M. kansasii isolates, respectively (Table 3).
|
View this table: [in a new window] |
TABLE 3. Identification by PNA-FISH of mycobacteria from 52 positive liquid cultures
|
![]() View larger version (4K): [in a new window] |
FIG. 1. Visualization by FISH (probe MTBCCy3) of human APC experimentally infected with M. bovis BCG.
|
![]() View larger version (67K): [in a new window] |
FIG. 2. Visualization by FISH (probe MTBCCy3) of M. tuberculosis H37Rv in a lung biopsy from an experimentally infected mouse. Same microscopic field visualized with a fluorescein filter set (A), showing background fluorescence allowing orientation within the tissue, and a Cy3-TAMRA filter set (B). The inset shows single mycobacterial cells.
|
![]() View larger version (107K): [in a new window] |
FIG. 3. Visualization by FISH (probe MTBCCy3) of M. tuberculosis in a lung biopsy from a tuberculosis patient. A and C, fluorescein filter set; B and D, Cy3-TAMRA filter set.
|
![]() View larger version (118K): [in a new window] |
FIG. 4. FISH (probe MLEPTAMRA) for detection of M. leprae in a tissue section from a case of leprosy. A and C, fluorescein filter set; B and D, Cy3-TAMRA filter set.
|
![]() View larger version (43K): [in a new window] |
FIG. 5. Detection of M. avium in a tissue section from a case of Johne's disease in a cow by FISH (probe MAVTAMRA). A and B, Cy3-TAMRA filter set.
|
|
|
|---|
Here we used four novel PNA probes to identify and visualize bacteria of the M. tuberculosis complex, as well as M. leprae, M. avium, and M. kansasii, in cultures and tissue sections.
To verify PNA-FISH for the detection of mycobacteria in the context of human cells, we first visualized single mycobacteria in BCG-infected APC as a well-defined experimental setting. Then we specifically detected M. tuberculosis, M. leprae, and M. avium subsp. paratuberculosis in tissue sections of human and animal origin. So far, conventional ISH procedures (3, 4, 7, 8, 17) or antibody-based methods (13, 18) have shown only colored spots. Bacterial morphology could not be assessed. FISH with fluorescein-labeled PNA probes improved the detection but needed a signal amplification step because of low fluorescence intensity (24). Labeling of our probes with TAMRA or Cy3 resulted in advanced signal intensity and succeeded in direct FISH detection of mycobacteria in tissues. Although some of these tissues were formaldehyde fixed and embedded years ago (human tuberculosis in 1999, leprosy in 2001, Johne's disease in 1999), we were able to detect mycobacteria with single-cell resolution.
In contrast to microscopic techniques like FISH, nucleic acid amplification-based methods are prone to contamination. In addition, they may be falsely negative because of the presence of amplification inhibitors such as eukaryotic and prokaryotic nontarget DNAs. In contrast, visualization of mycobacteria in a histopathological context allows unequivocal discrimination between true infection and contamination.
In addition, fluorescently labeled PNA probes represent an economical way to identify mycobacterial cultures isolated from clinical specimens. All 52 of the isolates included in this study were identified unequivocally as M. tuberculosis, M. avium, or M. kansasii, resulting in 100% sensitivity and specificity. Assuming a time to result of about 2.5 h with only 40 min of hands-on time for a FISH procedure (including fixation, hybridization, and microscopy) and considering its low cost, FISH might be an alternative to amplification-based methods for fast identification of commonly isolated mycobacterial species. An important advantage of using FISH is the fact that no biosafety level 3 laboratory is required.
The PNA-FISH probes shown here were able to distinguish between target sequences and sequences with single base mismatches. Probe composition and location of mismatches can limit the utility of PNA probes, and single base mismatches close to the 5' end of a probe complicated or even prevented specific hybridization, as shown by our experience with probes designed for M. intracellulare. There is little information on the effect of mismatch localization in PNA probes influencing hybridization specificity. According to our limited data set, a mismatch located in the middle of the probe has a better discriminative effect than a mismatch close to the 5' end.
Preliminary data show, however, that not all Ziehl-Neelsen-positive cells are visualized with PNA-FISH (data not shown). Further experiments will evaluate the performance of PNA-FISH in comparison with other methods (acid-fast staining, ISH with DNA probes, and amplification-based methods) for examination of tissue specimens.
In conclusion, we developed and validated four new PNA probes in an improved FISH procedure to identify and visualize mycobacteria in cultures from clinical specimens and directly within tissue sections. PNA-FISH was shown to be a fast and versatile tool for both clinical microbiology diagnostics and research purposes.
This work was supported in part by a grant from the Deutsche Forschungsgemeinschaft (Optimierte molekulare Bibliotheken, DFG no. GO 363/8-4) to U. B. Göbel. The epifluorescence microscope was a gift from the Sonnenfeld-Stiftung.
Present address: HAEMA AG, Institut für Medizinische Mikrobiologie am HELIOS-Klinikum Berlin-Buch, 13125 Berlin, Germany. ![]()
Present address: German Federal Ministry of Health, 10117 Berlin, Germany. ![]()
Present address: Actelion Pharmaceuticals Ltd., CH-4123 Allschwil, Switzerland. ![]()
¶ Present address: Institut für Pathologie und Neuropathologie, Universitätsklinikum Essen, D-45122 Essen, Germany. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»